COSTANZO, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 268
NA - Nord America 127
EU - Europa 21
SA - Sud America 19
AF - Africa 1
Totale 436
Nazione #
SG - Singapore 143
US - Stati Uniti d'America 123
CN - Cina 58
VN - Vietnam 41
BR - Brasile 11
IT - Italia 9
HK - Hong Kong 7
GB - Regno Unito 6
ID - Indonesia 3
AR - Argentina 2
EC - Ecuador 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
PY - Paraguay 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CA - Canada 1
FR - Francia 1
GT - Guatemala 1
IE - Irlanda 1
IN - India 1
JP - Giappone 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MY - Malesia 1
NL - Olanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 436
Città #
Singapore 66
San Jose 53
Ho Chi Minh City 12
Beijing 10
Ashburn 8
Boardman 7
Hanoi 6
Hong Kong 6
Council Bluffs 5
New York 5
Pisa 5
Los Angeles 3
Orem 3
Poplar 3
Santa Clara 3
Bến Tre 2
Da Nang 2
Dallas 2
Denver 2
Elk Grove Village 2
Mexico City 2
Porto Alegre 2
Salt Lake City 2
Warsaw 2
Amsterdam 1
Anápolis 1
Baku 1
Bauru 1
Belo Horizonte 1
Biên Hòa 1
Buffalo 1
Calgary 1
Campinas 1
Can Tho 1
Chelles 1
Chicago 1
Ciudad del Este 1
Cuiabá 1
Da Lat 1
Doha 1
Dolores 1
Dublin 1
Dūrā 1
Fortaleza 1
Glasgow 1
Guayaquil 1
Gujranwala 1
Ha Long 1
Hòa Bình 1
Kampong Loyang 1
Kuala Lumpur 1
Kuwait City 1
Lagomar 1
Lahore 1
Lanús 1
Le Roy 1
London 1
Lấp Vò 1
Manchester 1
Manila 1
Maracaibo 1
Matupá 1
Medan 1
Medina 1
Milan 1
Mumbai 1
Muscat 1
Ninh Bình 1
North Haven 1
Phnom Penh 1
Pouso Alegre 1
Quito 1
Quận Bình Thạnh 1
Reynoldsburg 1
Rio de Janeiro 1
San Lorenzo 1
Senago 1
Sfax 1
Tashkent 1
Tokyo 1
Tân An 1
Tân Tiến 1
Vinh 1
Warren Township 1
Washington 1
Totale 274
Nome #
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 40
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 40
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA–IL PSO (Italian Landscape Psoriasis) 39
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis) 38
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis) 36
Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS) 34
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 29
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) 24
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) 24
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience – IL PSO (Italian Landscape Psoriasis) 23
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 22
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 21
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis) 19
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis) 18
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis) 17
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis) 15
Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study— IL PSO ( Italian landscape psoriasis) 14
Totale 453
Categoria #
all - tutte 764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026453 0 0 0 25 123 66 67 34 39 99 0 0
Totale 453